The σ1 receptor, an endoplasmic reticulum–resident transmembrane protein, modulates many physiological and pathological processes and binds multiple drugs, but is nonetheless poorly understood. In a recent issue, Kruse and colleagues illustrate structural differences between agonist- and antagonist-bound receptor and propose that agonist binding may impair oligomerization, making a major step in understanding σ1 function. They also use a combination of kinetic and molecular dynamic modeling to explain how ligands access the binding pocket.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cobos, E. J., Entrena, J. M., Nieto, F. R., Cendán, C. M. & Del Pozo, E. Curr. Neuropharmacol. 6, 344–366 (2008).
Hanner, M. et al. Proc. Natl. Acad. Sci. USA 93, 8072–8077 (1996).
Seth, P., Leibach, F. H. & Ganapathy, V. Biochem. Biophys. Res. Commun. 241, 535–540 (1997).
Pan, Y. X. et al. J. Neurochem. 70, 2279–2285 (1998).
Ganapathy, M. E. et al. J. Pharmacol. Exp. Ther. 289, 251–260 (1999).
Schmidt, H. R. et al. Nature 532, 527–530 (2016).
Maurice, T. & Su, T. P. Pharmacol. Ther. 124, 195–206 (2009).
Maurice, T. & Goguadze, N. Handb. Exp. Pharmacol. 244, 81–108 (2017).
Merlos, M., Romero, L., Zamanillo, D., Plata-Salaman, C. & Vela, J. M. Handb. Exp. Pharmacol. 244, 131–161 (2017).
Kim, F. J. & Maher, C. M. Handb. Exp. Pharmacol. 244, 237–308 (2017).
Hayashi, T. & Su, T. P. Cell 131, 596–610 (2007).
Pasternak, G. W. Handb. Exp. Pharmacol. 244, 163–175 (2017).
Weber, F. et al. J. Med. Chem. 59, 5505–5519 (2016).
Laurini, E., Marson, D., Fermeglia, M. & Pricl, S. Handb. Exp. Pharmacol. 244, 27–50 (2017).
Kruse, A. Handb. Exp. Pharmacol. 244, 13–25 (2017).
Schmidt, H. R., Betz, R. M., Dror, R. O. & Kruse, A. C. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-018-0137-2 (2018).
Crottès, D., Guizouarn, H., Martin, P., Borgese, F. & Soriani, O. Front. Physiol. 4, 175 (2013).
Maher, C. M. et al. Mol. Cancer Res. 16, 243–255 (2018).
Thomas, J. D. et al. Cancer Res. 77, 2439–2452 (2017).
Weber, F. & Wunsch, B. Handb. Exp. Pharmacol. 244, 51–79 (2017).
Wacker, D. et al. Cell 168, 377–389.e312 (2017).
Acknowledgements
Supported by grants from the National Institute on Drug Abuse (DA07242 and DA06241), the Mayday Fund, and the McManus Charitable Trust to G.W.P.; a grant from the National Cancer Institute (CA08748) to SKI, MSKCC; and an American Cancer Society institutional research grant through the Sidney Kimmel Cancer Center at Thomas Jefferson University, a Drexel University Clinical and Translational Research Institute grant, and a Sidney Kimmel Cancer Center Consortium Pilot Study Award to F.J.K.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
F.J.K. is a cofounder of Context Therapeutics.
Rights and permissions
About this article
Cite this article
Kim, F.J., Pasternak, G.W. σ1 Receptor ligand binding: an open-and-shut case. Nat Struct Mol Biol 25, 992–993 (2018). https://doi.org/10.1038/s41594-018-0146-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41594-018-0146-1